Cargando…

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

Chronic hepatitis C is a major cause of chronic liver disease, including liver cirrhosis and hepatocellular carcinoma. The development of direct-acting antivirals (DAAs) revolutionized hepatitis C virus (HCV) treatment by offering genuine prospects for the first comprehensive cure of a chronic viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colpitts, Che C., Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997588/ https://www.ncbi.nlm.nih.gov/pubmed/27537906 http://dx.doi.org/10.3390/v8080226

Ejemplares similares

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
por: Verrier, Eloi R., et al.
Publicado: (2016)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches
por: Gallardo-Flores, Carla E., et al.
Publicado: (2021)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process
por: Colpitts, Che C., et al.
Publicado: (2020)

The Challenging Road to Hepatitis C Virus Eradication
por: Martínez, Isidoro, et al.
Publicado: (2021)

Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies
por: LeBlanc, Emmanuelle V., et al.
Publicado: (2021)

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018)

Hepatitis C virus exploits cyclophilin A to evade PKR
por: Colpitts, Che C, et al.
Publicado: (2020)

Challenges for addressing dementia
por: The Lancet Regional Health – Europe
Publicado: (2022)

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
por: Verrier, Eloi R., et al.
Publicado: (2016)

Boceprevir and personalized medicine in hepatitis C virus infection
por: Habersetzer, François, et al.
Publicado: (2012)

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care
por: Kang, Seong Hee, et al.
Publicado: (2021)

Insulin Resistance Provides the Connection Between Hepatitis C Virus and Diabetes
por: Safi, Sher Zaman, et al.
Publicado: (2014)

Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?
por: Prabhakar, Vijay, et al.
Publicado: (2019)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Treatment of people diagnosed with chronic hepatitis C virus infection
por: Bulterys, Marc, et al.
Publicado: (2018)

Europe’s collective failure to address the refugee crisis
por: Roberts, Bayard, et al.
Publicado: (2016)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Hepatitis C: the challenges to link patients to the cure
Publicado: (2019)

Addressing challenges faced by trial sites and investigators
por: Bavdekar, Sandeep B.
Publicado: (2021)

Optimizing Outcomes for Post-ECMO Heart Transplant Patients in South Korea: Addressing Multi-Organ Failure and Allocation Challenges
por: Kim, Kyung-Hee
Publicado: (2023)

New perspectives for preventing hepatitis C virus liver graft infection
por: Felmlee, Daniel J., et al.
Publicado: (2016)

Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions
por: Ridruejo, Ezequiel, et al.
Publicado: (2021)

Noma: Time to Address a Collective Moral Failure
por: Ravinetto, Raffaella
Publicado: (2017)

Public mental health: An opportunity to address implementation failure
por: Campion, Jonathan, et al.
Publicado: (2022)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Screening Strategies for Hepatitis C Virus
por: Lim, Aaron G., et al.
Publicado: (2019)

Advancements and lingering challenges in addressing public health disasters
por: Singer, Phillip M.
Publicado: (2020)

Novel Strategies to Address Critical Challenges in Pancreatic Cancer
por: Puik, Jisce R., et al.
Publicado: (2022)

Addressing the healthcare challenge: introducing Discover Health Systems
por: Catena, Rodolfo, et al.
Publicado: (2022)

Addressing sexually transmitted infections in Europe: challenges and strategies
por: The Lancet Regional Health – Europe
Publicado: (2023)

Treatment of Adolescents With Chronic Hepatitis C Virus Infection: New Regimen on the Block
por: Indolfi, Giuseppe, et al.
Publicado: (2018)

Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder
por: Talal, Andrew H., et al.
Publicado: (2023)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance
por: Günthard, Huldrych F., et al.
Publicado: (2016)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Extrahepatic manifestations in hepatitis C virus infection
por: Negro, Francesco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t9vfkmq4t519tbpqji3q0ne38s